FR2977494B1 - COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACIDS OF DIFFERENT MOLECULAR MASSES - Google Patents

COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACIDS OF DIFFERENT MOLECULAR MASSES

Info

Publication number
FR2977494B1
FR2977494B1 FR1102166A FR1102166A FR2977494B1 FR 2977494 B1 FR2977494 B1 FR 2977494B1 FR 1102166 A FR1102166 A FR 1102166A FR 1102166 A FR1102166 A FR 1102166A FR 2977494 B1 FR2977494 B1 FR 2977494B1
Authority
FR
France
Prior art keywords
different molecular
cosmetic
pharmaceutical compositions
hyaluronic acids
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1102166A
Other languages
French (fr)
Other versions
FR2977494A1 (en
Inventor
Correia Latifa Dahri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AYAWANE
Original Assignee
AYAWANE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AYAWANE filed Critical AYAWANE
Priority to FR1102166A priority Critical patent/FR2977494B1/en
Publication of FR2977494A1 publication Critical patent/FR2977494A1/en
Application granted granted Critical
Publication of FR2977494B1 publication Critical patent/FR2977494B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/592—Mixtures of compounds complementing their respective functions
    • A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2205/00—Polymer mixtures characterised by other features
    • C08L2205/02—Polymer mixtures characterised by other features containing two or more polymers of the same C08L -group

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Composition comprises a mixture of hyaluronic acids (HA) having different molecular weights, where the molecular weight of HA has a width of greater than D+- 0.5D, preferably greater than D+- 0.7D, and D is the center value. ACTIVITY : Vulnerary; Antiarthritic; Osteopathic; Dermatological. MECHANISM OF ACTION : None given.
FR1102166A 2011-07-08 2011-07-08 COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACIDS OF DIFFERENT MOLECULAR MASSES Active FR2977494B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1102166A FR2977494B1 (en) 2011-07-08 2011-07-08 COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACIDS OF DIFFERENT MOLECULAR MASSES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1102166A FR2977494B1 (en) 2011-07-08 2011-07-08 COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACIDS OF DIFFERENT MOLECULAR MASSES

Publications (2)

Publication Number Publication Date
FR2977494A1 FR2977494A1 (en) 2013-01-11
FR2977494B1 true FR2977494B1 (en) 2013-08-16

Family

ID=45495957

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1102166A Active FR2977494B1 (en) 2011-07-08 2011-07-08 COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACIDS OF DIFFERENT MOLECULAR MASSES

Country Status (1)

Country Link
FR (1) FR2977494B1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3004353B1 (en) * 2013-04-10 2015-05-15 Fabre Pierre Dermo Cosmetique SYNERGISTIC ASSOCIATION OF ALANINE-GLUTAMINE, HYALURONIC ACID AND OAT EXTRACT, AND USE THEREOF IN A COMPOSITION FOR SCALING AND REPAIRING SKIN LESIONS
EP2985027B1 (en) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
EP2985019B1 (en) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
IT201900024208A1 (en) * 2019-12-17 2021-06-17 Altergon Sa INJECTABLE MIXTURES OF HYALURONIC ACID FOR USE IN DERMOESTHETICS
CN116059241A (en) * 2021-11-04 2023-05-05 华熙生物科技股份有限公司 Composition containing hyaluronic acid or salt thereof for improving immunity and promoting gastrointestinal health and application thereof
FR3130156A1 (en) * 2021-12-10 2023-06-16 Lvmh Recherche Combination of cross-linked, high molecular weight hyaluronic acid and non-cross-linked, low molecular weight hyaluronic acid.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
ITMI20021866A1 (en) * 2002-08-30 2004-02-29 Luigi Allegra PHARMACEUTICAL PREPARATION IN COLLOIDAL FORM USEFUL IN THE TREATMENT OF SKIN DISEASES.
US7060691B2 (en) * 2002-10-10 2006-06-13 Giuseppe Petrigni Pharmaceutical colloidal preparation useful in the treatment of respiratory diseases
EP2133066A1 (en) * 2008-06-13 2009-12-16 Antonio Puig, S.A. Cosmetic and dermatological composition containing a mixture of retinol derivatives and tocotrienols.
IT1391652B1 (en) * 2008-08-20 2012-01-17 Nobil Bio Ricerche Srl DEVICE FOR PLANT
US20100098794A1 (en) * 2008-10-17 2010-04-22 Armand Gerard Topical anti-wrinkle and anti-aging moisturizing cream
TWI516269B (en) * 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 Mixture of hyaluronic acid for treating and preventing inflammatory bowel disease

Also Published As

Publication number Publication date
FR2977494A1 (en) 2013-01-11

Similar Documents

Publication Publication Date Title
FR2977494B1 (en) COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING HYALURONIC ACIDS OF DIFFERENT MOLECULAR MASSES
EA201200551A1 (en) PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSED FORM, METHODS OF THEIR PRODUCTION AND APPLICATION FOR TREATMENT
BR112012027034A2 (en) arginase inhibitors and their therapeutic applications
MA33045B1 (en) PHARMACEUTICAL COMPOSITION CONTAINING LINAGLIPTIN AND OPTIONALLY SGLT-2 INHIBITOR, AND USES THEREOF
AU2012253759A8 (en) Tricyclic sulfonamide compounds and methods of making and using same
CY1118813T1 (en) PHARMACEUTICAL COMPOSITIONS OF TRAMADOL AND COXYL-CYLINDERS
EA201101192A1 (en) PHARMACEUTICAL COMPOSITION, INCLUDING DERIVATIVES GLUCOPIRANZYDHYPHENILMETHANE, PHARMACEUTICAL DOSED FORM, CONTAINING INDICATED DERIVATIVES, METHOD OF THEIR RECEIVING APPLICATIONS
EA200870216A1 (en) AMIDO COMPOUNDS AND THEIR APPLICATION AS MEDICINES
BR112012028091A2 (en) pharmaceutical compositions comprising pioglitazone and linagliptin
AU2012253757A8 (en) Partially saturated tricyclic compounds and methods of making and using same
BR112013015855A2 (en) compound, use of a compound, methods of prevention, treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications; and, pharmaceutical composition.
MX344238B (en) Tetrazole compounds and methods of making and using same.
BR112014016165A8 (en) Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation
EA201391786A1 (en) HALOGEN-ALKYL-1,3-OXAZINS AS BACE1 AND / OR BACE2 INHIBITORS
EA201290836A1 (en) RELATED BIS-ARYL ARYLTRIAZOLONES AND THEIR APPLICATION
EA201291336A1 (en) SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINE AND THEIR APPLICATION
MX2013007558A (en) 1,4 oxazines as bace1 and/or bace2 inhibitors.
EA201201658A1 (en) DERIVATIVES OF PIPERIDINE AND THEIR APPLICATION FOR THE TREATMENT OF METABOLIC DISORDERS
EA201400771A1 (en) NEW AZETIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION
UA110642C2 (en) Composition of herbicide and safeneru
BR112013017314A2 (en) compositions comprising sodium glucose co-transporter 1 and 2 inhibitors and methods of use
FR2961814B1 (en) NOVEL SIRTUIN 6 ACTIVATOR PEPTIDES AND COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING SAME.
WO2013061004A8 (en) Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
BR112013015877A2 (en) compound, use of a compound, prevention methods. treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications, and, pharmaceutical composition.
BR112012019868A2 (en) pharmaceutical composition for topical use

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14